ARTICLE | Politics, Policy & Law
Scientists warn Trump immigration ‘pause’ will harm biopharma innovation
June 23, 2020 4:41 PM UTC
Updated on Jun 23, 2020 at 10:32 PM UTC
President Donald Trump’s decision to bar most employment-based visas through year-end could have a broad impact on the U.S. biopharma industry, which is heavily dependent on temporary and permanent immigrants to fill jobs from junior scientists to CEOs.
In addition to the proclamation, a broad exemption in an April 22 ban for individuals involved in medical fields, including research, has been narrowed to apply only to individuals working directly on COVID-19. ...